Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
- PMID: 33707831
- PMCID: PMC7900311
- DOI: 10.1007/s12288-020-01295-8
Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
Abstract
B cell lineage acute lymphoblastic leukemia is the most common leukemia occurring in children and young adults and is the leading cause of cancer related deaths. The 5 year overall survival outcome in children with B-ALL has improved significantly in the last few decades. In the past, the discovery of various genetic alterations and targeted therapy have played a major role in decreasing disease-related deaths. In addition, numerous advances in the pathogenesis of B-ALL have been found which have provided better understanding of the genes involved in disease biology with respect to diagnostic and prognostic implications. Present review will summarize current understanding of risk stratification, genetic factors including cytogenetics in diagnosis and prognosis of B-ALL.
Keywords: Targeted therapy; Copy number alterations; Cytogenetic risk groups.
© Indian Society of Hematology and Blood Transfusion 2020.
Figures
Similar articles
-
Study of Cytogenetic Alterations and Association With Prognostic Factors in Indian Children With B-Lineage Acute Lymphoblastic Leukemia.Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e346-e351. doi: 10.1016/j.clml.2019.09.603. Epub 2020 Mar 7. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32279950
-
Prognostic Impact of Somatic Copy Number Alterations in Childhood B-Lineage Acute Lymphoblastic Leukemia.Curr Oncol Rep. 2020 Nov 14;23(1):2. doi: 10.1007/s11912-020-00998-5. Curr Oncol Rep. 2020. PMID: 33190177 Review.
-
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.Haematologica. 2013 Jul;98(7):1081-8. doi: 10.3324/haematol.2013.085175. Epub 2013 Mar 18. Haematologica. 2013. PMID: 23508010 Free PMC article. Clinical Trial.
-
Prognostic and Predictive Biomarkers in Precursor B-cell Acute Lymphoblastic Leukemia.In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 10. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 10. PMID: 36395319 Free Books & Documents. Review.
-
Advances in the molecular pathobiology of B-lymphoblastic leukemia.Hum Pathol. 2012 Sep;43(9):1347-62. doi: 10.1016/j.humpath.2012.02.004. Epub 2012 May 8. Hum Pathol. 2012. PMID: 22575265 Review.
Cited by
-
Clinical features and prognosis of acute lymphoblastic leukemia in children with Epstein-Barr virus infection.Transl Pediatr. 2022 May;11(5):642-650. doi: 10.21037/tp-22-146. Transl Pediatr. 2022. PMID: 35685069 Free PMC article.
-
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients' outcome.Ann Hematol. 2025 Mar;104(3):1821-1832. doi: 10.1007/s00277-024-06102-2. Epub 2024 Nov 26. Ann Hematol. 2025. PMID: 39589495 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous